drugset / Trial / NCT00167479
A Study of Risperidone Monotherapy in Bipolar Anxiety
RandomizedParallel-groupDouble-blindTreatment
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of risperidone monotherapy in the treatment of ambulatory bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.
Timeline
- Start
- 2003-09
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | — | — |